Header Logo

Connection

Julie Schneider to Genotype

Back to Details
This is a "connection" page, showing publications Julie Schneider has written about Genotype.
Julie Schneider
Connection Strength
1.641
Genotype
  1. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimers Dement. 2019 02; 15(2):258-266.
    View in: PubMed
    Score: 0.577
  2. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015 Nov; 36(11):2946-2953.
    View in: PubMed
    Score: 0.116
  3. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology. 2009 Apr 28; 72(17):1495-503.
    View in: PubMed
    Score: 0.075
  4. Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults. JAMA Neurol. 2023 09 01; 80(9):929-939.
    View in: PubMed
    Score: 0.051
  5. Sex differences in associations between APOE e2 and longitudinal cognitive decline. Alzheimers Dement. 2023 10; 19(10):4651-4661.
    View in: PubMed
    Score: 0.049
  6. RNASE6 is a novel modifier of APOE-e4 effects on cognition. Neurobiol Aging. 2022 10; 118:66-76.
    View in: PubMed
    Score: 0.047
  7. Genetic variants and functional pathways associated with resilience to Alzheimer's disease. Brain. 2020 08 01; 143(8):2561-2575.
    View in: PubMed
    Score: 0.041
  8. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020 02 03; 11(1):667.
    View in: PubMed
    Score: 0.040
  9. APOE e4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease. Neurobiol Aging. 2020 03; 87:18-25.
    View in: PubMed
    Score: 0.039
  10. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat Commun. 2019 01 24; 10(1):409.
    View in: PubMed
    Score: 0.037
  11. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018 08 01; 75(8):989-998.
    View in: PubMed
    Score: 0.036
  12. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain. Mol Neurodegener. 2018 07 24; 13(1):38.
    View in: PubMed
    Score: 0.036
  13. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol. 2018 12; 136(6):857-872.
    View in: PubMed
    Score: 0.035
  14. APOE e2e4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology. 2018 06 12; 90(24):e2127-e2134.
    View in: PubMed
    Score: 0.035
  15. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 09; 49(9):1373-1384.
    View in: PubMed
    Score: 0.033
  16. Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline. Alzheimers Dement. 2017 Dec; 13(12):1380-1388.
    View in: PubMed
    Score: 0.033
  17. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data. PLoS Med. 2017 04; 14(4):e1002287.
    View in: PubMed
    Score: 0.033
  18. Genetic epistasis regulates amyloid deposition in resilient aging. Alzheimers Dement. 2017 Oct; 13(10):1107-1116.
    View in: PubMed
    Score: 0.032
  19. Role of APOE e4 Allele and Incident Stroke on Cognitive Decline and Mortality. Alzheimer Dis Assoc Disord. 2016 Oct-Dec; 30(4):318-323.
    View in: PubMed
    Score: 0.031
  20. The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults. PLoS One. 2016; 11(7):e0157452.
    View in: PubMed
    Score: 0.031
  21. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol. 2015 Feb; 72(2):209-16.
    View in: PubMed
    Score: 0.028
  22. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol. 2014 Nov; 71(11):1394-404.
    View in: PubMed
    Score: 0.027
  23. Modification of the relationship of the apolipoprotein E e4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 2013 Dec; 70(12):1544-51.
    View in: PubMed
    Score: 0.026
  24. Genetic susceptibility for Alzheimer disease neuritic plaque pathology. JAMA Neurol. 2013 Sep 01; 70(9):1150-7.
    View in: PubMed
    Score: 0.025
  25. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013 Jul; 16(7):848-50.
    View in: PubMed
    Score: 0.025
  26. APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
    View in: PubMed
    Score: 0.025
  27. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 2012 Jul 17; 79(3):221-8.
    View in: PubMed
    Score: 0.023
  28. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011 Mar; 69(3):560-9.
    View in: PubMed
    Score: 0.021
  29. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010 Mar; 42(3):234-9.
    View in: PubMed
    Score: 0.020
  30. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005 Jun; 62(6):685-91.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.